MicroRNA-203 Modulation for Pluripotent Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reprogramming somatic cells into induced pluripotent stem cells (iPSCs) face low efficiency and safety concerns, with limited differentiation potential and quality issues affecting their utility in regenerative medicine.
Innovation Solution
Transient exposure to increased levels of microRNA-203 enhances stemness and differentiation potential of pluripotent cells, including iPSCs and embryonic stem cells, by promoting a naïve pluripotent state and improving differentiation into multiple lineages.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If transient exposure to increased levels of microRNA-203 is applied to pluripotent cells, then stemness and differentiation potential are enhanced, but the complexity of the reprogramming process increases
Solution Approach 1:
The patent applies parameter changes by modulating the concentration and temporal expression of microRNA-203 during the reprogramming process. By controlling the level (increased levels) and duration (transient exposure) of miR-203, the method enhances stemness and differentiation potential without requiring complex multi-factor interventions, thus resolving the contradiction between improved productivity and process complexity
2Adaptability or versatility
If conventional reprogramming methods are used to generate iPSCs, then the basic pluripotent state is achieved, but differentiation potential and quality are limited
Solution Approach 1:
The patent introduces microRNA-203 as an intermediary molecule that mediates between the basic reprogramming process and the desired enhanced differentiation potential. This intermediary miR-203 bridges the gap by acting on existing pluripotent cells to expand their differentiation capacity and improve quality, without requiring a complete redesign of the reprogramming methodology
3Productivity
If reprogramming efficiency is increased through conventional methods, then more iPSCs are generated, but safety concerns and quality issues persist
Solution Approach 1:
The patent employs a transient, short-term exposure to microRNA-203 rather than sustained or permanent modification. This temporary intervention (disposable approach) achieves enhanced reprogramming efficiency and cell quality without the long-term safety concerns associated with permanent genetic modification or sustained expression of reprogramming factors, thus resolving the contradiction between productivity and safety
Data Source
AI summary
Method for expanding stemness and differentiation potential of pluripotent cells. The invention is based on the finding that increasing micro RNA-203 levels in induced pluripotent stem (iPSCs) or embryonic stem (ESCs) cells improves the quality cell fate potential and ability of these cells to differentiate into multiple cell lineages and to reach further maturation properties without interfering with their self-renewal properties. This effect is mediated through the mi R-203-dependent control of de novo DNA methyltransferases Dnmt3a and Dnmt3b, which in turn regulate the methylation landscape of pluripotent cells. The effect can be achieved by overexpression of micro RNA-203 or by adding micro RNA-203 or analogues thereof to the cell culture medium and can be observed using a variety of cellular and in vivo models. The generated cells are naïve pluripotent cells with an improved capacity to differentiate, that can be used to obtain more efficiently differentiated and mature cells proficient for regenerative medicine strategies.